These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases. Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP Mod Pathol; 2024 Jun; 37(6):100494. PubMed ID: 38621503 [TBL] [Abstract][Full Text] [Related]
4. GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH. Palsgrove DN; Rooper LM; Stevens TM; Shin C; Damm DD; Gagan J; Bridge JA; Thompson LDR; Koduru PR; Bishop JA Head Neck Pathol; 2022 Dec; 16(4):1146-1156. PubMed ID: 35933574 [TBL] [Abstract][Full Text] [Related]
5. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978 [TBL] [Abstract][Full Text] [Related]
6. MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas. Grünewald I; Trautmann M; Busch A; Bauer L; Huss S; Schweinshaupt P; Vollbrecht C; Odenthal M; Quaas A; Büttner R; Meyer MF; Beutner D; Hüttenbrink KB; Wardelmann E; Stenner M; Hartmann W Oncotarget; 2016 Nov; 7(46):75261-75272. PubMed ID: 27662657 [TBL] [Abstract][Full Text] [Related]
7. Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology. Machado I; Hosler GA; Traves V; Claramunt R; Sanmartín O; Santonja C; Carvajal N; Zazo S; Requena L; Alfonso VS; Domenech EV; Llombart-Bosch A; Bridge JA; Linos K J Cutan Pathol; 2023 Jun; 50(6):487-499. PubMed ID: 36316249 [TBL] [Abstract][Full Text] [Related]
8. Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis. Xu B; Chang K; Folpe AL; Kao YC; Wey SL; Huang HY; Gill AJ; Rooper L; Bishop JA; Dickson BC; Lee JC; Antonescu CR Am J Surg Pathol; 2020 Jun; 44(6):729-737. PubMed ID: 31934916 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171 [TBL] [Abstract][Full Text] [Related]
10. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873 [TBL] [Abstract][Full Text] [Related]
11. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions. Agaram NP; Zhang L; Sung YS; Singer S; Stevens T; Prieto-Granada CN; Bishop JA; Wood BA; Swanson D; Dickson BC; Antonescu CR Mod Pathol; 2019 Nov; 32(11):1617-1626. PubMed ID: 31189998 [TBL] [Abstract][Full Text] [Related]
12. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848 [TBL] [Abstract][Full Text] [Related]
13. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Lopes MA; Nikitakis NG; Ord RA; Sauk J Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526 [TBL] [Abstract][Full Text] [Related]
15. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854 [TBL] [Abstract][Full Text] [Related]
16. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477 [TBL] [Abstract][Full Text] [Related]
17. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH). Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065 [TBL] [Abstract][Full Text] [Related]
18. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207 [TBL] [Abstract][Full Text] [Related]
19. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260 [TBL] [Abstract][Full Text] [Related]
20. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]